Loading…
20,252 grants found
Showing 961 – 980 of 20,252 grants
PROJECT SUMMARY/ABSTRACT Colorectal cancer (CRC) is a devastating disease with no effective therapeutic options for patients suffering from advanced metastasis. Immune checkpoint i...
SUMMARY/ABSTRACT Cancer associated fibroblasts and pancreatic stellate cells (PSC/CAF) and abnormal tumor blood vessels are two major factors that contribute to treatment failure....
PROJECT SUMMARY/ABSTRACT The recent successes of checkpoint blockade therapies have highlighted the potential of immunotherapy for cancer treatment. Still, only about 30% of treatm...
Tumor blood vessels are dysfunctional and irregular, impairing immune cell infiltration and drug delivery and creating areas of severe hypoxia that select for aggressive cancer cel...
Project Summary Diffuse midline gliomas (DMG) are the most common malignant brain tumors of children. They are surgically inaccessible and refractive to chemotherapy. The prevalent...
PROJECT SUMMARY/ABSTRACT Pancreatic ductal adenocarcinoma (PDA) is projected to be the second leading cause of cancer deaths in the US by 2030. With no cost-effective screening or...
SUMMARY The achievements obtained with different types of cancer immunotherapy are clear, with durable long-term survival in some cases. The most frequently used immunotherapeutic...
PROJECT SUMMARY Ewing sarcoma is a pediatric bone and soft tissue cancer that results from chromosomal translocation, most commonly t(11;22)(q24;q12), which fuses the low-complexit...
PROJECT SUMMARY: Breast cancer is the most common form of malignancy in women, accounting for almost one in three new female cancer diagnoses each year. The primary cause of breast...
PROJECT SUMMARY/ABSTRACT Malignant gliomas are the most common primary adult brain cancer, affecting over 20,000 Americans each year. While molecularly targeted therapies have demo...
Cervical cancer remains the second most common cancer killer of women worldwide, with an annual incidence of more than 600,000 and an annual death rate of 300,000. Further, cervica...
Project Summary Multiple myeloma (MM) is an incurable malignancy of mature plasma cells accounting for 1.8% of new cancer cases annually, and 10% of hematological malignancies. Imm...
Project Summary The -omics era has made it possible to identify several molecular markers involved in predicting survival and response to therapies. We currently lack an easy way t...
Project Summary Several aggressive types of breast cancer (BCa) are nutritionally reliant on glutamine metabolism, and glutamine uptake has been shown to be enhanced in BCa bone-ho...
Metastatic prostate cancer remains incurable and inevitably progresses to lethal disease despite expanding treatment options.Standard of care includes therapies targeting the andro...
Project Summary: Pancreatic ductal adenocarcinoma (PDAC) is a solid tumor with limited treatment options and a dismal five-year survival rate of only 12%, necessitating the develop...
Project Summary Specific Aims Solid tumors account for nearly 90% of adult cancers and are challenging to eliminate. Surgery and adjuvant therapy (e.g., radiation, chemotherapy, an...
Abstract Glioblastoma multiforme (GBM) is an aggressive primary brain tumor with a median survival of approximately 15 months. Currently, the standard of care therapy includes rese...
Project Summary/Abstract: Caspase-8 is the primary protein that drives the extrinsic apoptotic pathway, and is frequently mutated, contains polymorphisms, or downregulated in vario...
PROJECT SUMMARY Cell communication research is a growing field that is complimentary to, but distinct from, traditional signal trans- duction fields. This emerging field emphasizes...